Search
Now showing items 1-1 of 1
Anti-cancer activity of novel camptothecin analogues that are insensitive to ABCG2
(2015)
Analogues of camptothecin (CPT) have been used in the clinic for almost two decades. The first analogue to be approved, topotecan (TPT), is now approved for use in patients with advanced ovarian, cervical, or small cell ...